Compare Hormel Foods Corp (HRL) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hormel Foods Corp vs Pfizer Inc — how do they compare? Hormel Foods Corp trades at $25.19 (market cap $13.91B), while Pfizer Inc trades at $24.93 (market cap $141.06B). The key difference: Pfizer Inc is far larger — about 10.1× Hormel Foods Corp's market cap, and Pfizer Inc pays the higher dividend (6.95%). Which is the better fit depends on your goals.
| HRL | PFE | |
|---|---|---|
Market Cap | $13.91B | $141.06B |
Sector | Consumer Staples | Health |
52-Week High | $29.52 | $28.56 |
52-Week Low | $19.74 | $23.29 |
Enterprise Value | $15.91B | $191.72B |
Dividend Yield | 4.63% | 6.95% |
Volume | — | 29,869,932 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hormel Foods (HRL) trades at $25.115, down 1.1% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported revenue of $12.11B in 2025 with a net income margin of 3.82%, and has beaten EPS estimates for three consecutive quarters. Recent news highlights its status as a Dividend King with 60 consecutive years of dividend increases, and the sale of its Ceratti business in Brazil aims to streamline international operations.
Outlook remains cautious with modest growth projections; the stock offers a reliable dividend but faces margin pressures and competitive headwinds. Analyst consensus is mixed with a $26.33 price target, suggesting limited upside. Key risks include earnings volatility and macroeconomic impacts on consumer staples demand.
Pfizer (PFE) trades at $25.05, down 0.36% on the day, with a bullish technical signal supported by strong quarterly earnings beats. The company maintains solid profitability with a 73.51% gross margin and 11.83% net income margin, though revenue has moderated post-pandemic. Recent news highlights pipeline advancements in oncology and obesity treatments, positioning PFE for potential growth catalysts in 2026.
The outlook for Pfizer is cautiously optimistic, with a consensus price target of $28.25 offering 13% upside. Key opportunities include dividend stability and pipeline innovation, while risks involve patent cliffs and competitive pressures. Analyst sentiment is mixed with 38% buy ratings, reflecting balanced views on recovery potential versus near-term challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
